期刊文献+

胃食管反流性咳嗽的临床诊断分析 被引量:3

Clinical analysis of gastroesophageal reflux cough
原文传递
导出
摘要 目的:探讨胃食管反流(GER)性咳嗽的临床特征、诊断和治疗。方法:对33例X线胸片、组胺激发试验、鼻部检查正常的慢性咳嗽患者进行24h食管pH监测,并利用症状相关性概率(SAP)来分析咳嗽与反流的相关性。对Demeester总积分≥14.72,和(或)咳嗽与反流SAP≥75%者进行为期12周的抗反流治疗。结果:33例患者中,有23例诊断为GER性咳嗽,并给予抗反流治疗,完成疗程后,有12例患者咳嗽完全消失,咳嗽与反流的SAP(上电极为0.80±0.18,下电极为0.87±0.11)显著高于另11例对抗反流治疗反应较差或无效的患者(上电极为0.39±0.27,下电极为0.48±0.31;P<0.05)。结论:GER是不明原因慢性咳嗽的一个重要的独立原因。24h食管pH监测结合症状相关性分析有助于GER性咳嗽的诊断,抗反流治疗对其有较好的近期疗效。 Objective: To investigate the clinical features , diagnosis and management of gastroesophageal reflux induced cough (GERC). Methods: The continuous ambulatory esophageal pH measurement was performed for 24 hour in 33 cases with chronic cough who had normal chest roentgenographic presentation, negative histamine provocation test and no abnormality of nasal cavity. The symptom association probability ( SAP ) was adopted to analyze the correlation of cough with gastroesophageal reflux. The anti-reflux treatment was given for 12 weeks to those patients with Demeester score ≥14.72 and/ or SAP ≥75 %. Results: Twenty three out of 33 cases were diagnosed as patients with gastroesophageal reflux.The cough was completely cured in 12 cases after antireflux treatment. The SAP of cough in this cured group (proximal probe0.80 ±0.18,distal probe0.87 ±0.11respectively) was significantly higher than that of patients who failed in response to antireflux treatment (proximal probe 0.39 ±0.27 ,distal probe 0.48 ±0.31, respectively , P 〈 0.05). Conclusion: The gastroesophageal reflux may be an independent factor which could induce chronic cough. Not only the frequency and severity of gastroesophageal reflux but also the SAP were helpful in making the diagnosis of GERC. Satisfied effect was achieved after sufficient anti-reflux treatment in patients with GERC.
出处 《现代生物医学进展》 CAS 2010年第19期3708-3710,共3页 Progress in Modern Biomedicine
关键词 胃食管反流 咳嗽 症状相关性 Gastroesophageal reflux; Cough; Symptom relativity
  • 相关文献

参考文献12

  • 1Johnson L F, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system [J]. J ClinGastroenterol, 1986,8 Suppl 1:52-58.
  • 2Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom association probability : an improved method for symptom analysis of 24-hour esophageal pH data [J]. Gastroenterology, 1994,107: 1741-1745.
  • 3朱礼星,马洪明,赖克方,李颖,钟淑卿,吴华,钟南山.胃食管反流性咳嗽的临床分析[J].中华内科杂志,2003,42(7):461-465. 被引量:79
  • 4Irwin RS.The diagnosis and treatment of cough [J].N Engl J Med, 2000,343(23): 1715-1721.
  • 5VakilN, van Zanten SV, Kahrilas P, etal. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus [J]. Am J Gastroenterol, 2006, 101:1900-1920.
  • 6Irwin RS, French CL, Curley FJ, et al. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic,and pathogenetic aspects [J]. Chest,1993,104(5) :1511-1517.
  • 7Wunderlich AW, Murray JA. Temporal correlation between chronic cough and gast roesophageal reflux disease. Dig Dis Sci, 2003,48 (6): 1050-1056.
  • 8Harding SM, Richter J E, Guzzo MR, et al. Asthma and gastroesophageal reflux : acid suppressive therapy improves asthma outcome [J]. Am J Med ,1996,100:395-405.
  • 9Vaezi MF , Shay SS. New techniques in measuring nonacidic esophageal reflux [J]. Semin Thorac Cardiovasc Surg, 2001, 13: 255-264.
  • 10Kiljander TO. The role of proton pump inhibitors in the management of gast roesophageal reflux disease-related asthma and chronic cough [J]. Am J Med, 2003,115 (Suppl 3A) :65S-71S.

二级参考文献1

  • 1David S. Thoman M.D.,Thomas T. Hui M.D.,Maria Spyrou M.D.,Edward H. Phillips M.D., F.A.C.S.. Laparoscopic antireflux surgery and its effect on cough in patients with gastroesophageal reflux disease[J] 2002,Journal of Gastrointestinal Surgery(1):17~21

共引文献78

同被引文献34

  • 1夏志伟,段卓洋,张莉,徐志洁,段丽萍.精神心理因素与不同亚型胃食管反流病的相关性研究[J].中华消化杂志,2007,27(7):447-449. 被引量:35
  • 2Kinoshita Y,Miwa H,Kasugai K. Efficacy of esomeprazole compared with omeprazole in reflux esophagitis patients-a phase Ⅲ,multicenter,randomized,double-blind,parallel-group trial[J].Nihon Shokakibyo Gakkai Zasshi,2013,(2):234-242.
  • 3Kinoshita Y,Hongo M,Japan 'TWICE Study' Group. Efficacy of twice daily rabeprazole for reflux esophagitis patients refractory to standard once daily administration of PPI:the Japan-based TWICE study[J].The American Journal of Gastroenterology,2012,(4):522-530.
  • 4Park JH,Park H,Lee DH. A randomized double-blinded clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease[J].J Neurogastroenterol Motil,2013,(2):219-226.
  • 5lida H,Inamori M,Fujii T. Early effect of oral administration of om eprazole with mosapride as compared with those of omeprazole alone on the intragastric pH[J].{H}BMC Gastroenterology,2012,(12):25.
  • 6Kallel L,Bibani N,Fekih M. Metabolic syndrome is associated with gastroesophageal reflux disease based on a 24-hour ambulatory pH monitoring[J].Diseases of the Esophagus,2011,(3):153-159.
  • 7Nagahara A,Hojo M,Asaoka D. Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy[J].{H}Journal of Gastroenterology,2012,(Suppl 3):53-57.
  • 8Keller G A,Czerniuk P,Bertuola R. Relative bioavailability of a 5mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers:a single-dose randomized open-label crossover study[J].{H}CURRENT MEDICAL RESEARCH AND OPINION,2011,(11):2203-2211.
  • 9Filik L. Long-term maintenance therapy with rabeprazole for reflux esophagitis[J].{H}Journal of Internal Medicine,2011,(11):1267.
  • 10Zhang Jun-han,Li Hai-min,Qiao Jin-biao. The investigationand study of the risk factors for gastroesophageal reflux disease[J].Clinical assemble,2011,(4):492-496.

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部